BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4016728)

  • 1. High affinity rosette forming cells in carcinoma of the oral cavity, uterine cervix and breast.
    Vijayakumar T; Vasudevan DM
    Cancer Lett; 1985 Jul; 27(3):339-45. PubMed ID: 4016728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell mediated and humoral immune responses in oral submucous fibrosis.
    Rajendran R; Sugathan CK; Remani P; Ankathil R; Vijayakumar T
    Cancer; 1986 Dec; 58(12):2628-31. PubMed ID: 3779612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum immunoglobulins in patients with carcinoma of the oral cavity, uterine cervix and breast.
    Vijayakumar T; Ankathil R; Remani P; Sasidharan VK; Vijayan KK; Vasudevan DM
    Cancer Immunol Immunother; 1986; 22(1):76-9. PubMed ID: 3708632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with carcinoma of the oral cavity, uterine cervix, and breast.
    Vijayakumar T; Ankathil R; Remani P; Beevi VM; Vijayan KK; Panicker CK
    J Clin Immunol; 1987 Jul; 7(4):300-3. PubMed ID: 3611297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-affinity erythrocyte rosette formation and inhibition in premalignant disease of the uterine cervix.
    Bashford J; Gough IR
    Cancer Res; 1983 Aug; 43(8):3955-8. PubMed ID: 6861158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated and humoral immune responses in patients with localized juvenile periodontitis.
    Anil S; Hari S; Remani P; Vijayakumar T; Ankathil R
    Bull Kanagawa Dent Coll; 1990 Mar; 18(1):3-6. PubMed ID: 2133794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunology of chronic generalized periodontitis. 1. Estimation of cellular and humoral immune status.
    Anil S; Hari S; Remani P; Vijaykumar T
    Indian J Dent Res; 1990; 2(1):127-32. PubMed ID: 2096956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-rosette forming lymphocytes in carcinoma of uterine cervix patients before and after treatment.
    Singh RP; Shukla M; Singh VP; Udupa KN
    J Assoc Physicians India; 1987 Mar; 35(3):211-2. PubMed ID: 3497155
    [No Abstract]   [Full Text] [Related]  

  • 9. [Circulating T cells in patients with breast or genital cancers in the pre-therapeutic phase].
    Strache RR; Büttner HH; Kunze M; Röpcke G
    Zentralbl Gynakol; 1989; 111(12):816-23. PubMed ID: 2788342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ["In vivo" and "in vitro" immunological monitoring in carcinoma of the uterine cervix].
    Sacco F; Benedetti Panici P; Di Roberto P; Margariti PA; Villani L; Laghi V; Cauda R; Nervo P
    Minerva Ginecol; 1982 Apr; 34(4):259-64. PubMed ID: 7048137
    [No Abstract]   [Full Text] [Related]  

  • 11. Rosette formation and inhibition in cervical dysplasia and carcinoma in situ.
    Sawanobori S; Ashman RB; Nahmias AJ; Benigno BB; LaVia MF
    Cancer Res; 1977 Dec; 37(12):4332-5. PubMed ID: 922724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of rosette forming T-lymphocytes in carcinoma of cervix uteri.
    Utreja SR; Ramdeo IN; Kalra VB; Lodha SK; Sareen PM
    Indian J Cancer; 1980 Dec; 17(4):216-9. PubMed ID: 6971798
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence of hepatitis B surface antigen (HBsAg) in oral cancer and carcinoma of uterine cervix.
    Vijayakumar T; Sasidharan VK; Ankathil R; Remani P; Kumari TV; Vasudevan DM
    Indian J Cancer; 1984; 21(1):7-10. PubMed ID: 6510943
    [No Abstract]   [Full Text] [Related]  

  • 14. [Humoral and cellular immune response to cryosurgery of benign and malignant lesions of the oral cavity].
    Fazio M; Airoldi M; Gandolfo S; Mastromatteo V; Negri I; Pecchio F; Sartoris S
    Boll Soc Ital Biol Sper; 1982 Apr; 58(7):412-8. PubMed ID: 7082479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression of high-affinity rosette formation in dysplasia and carcinoma in situ of the uterine cervix: mediation by serum factors.
    Bashford J; Gough IR
    Cancer Res; 1983 Aug; 43(8):3959-62. PubMed ID: 6861159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological abnormalities in patients with cervical carcinoma.
    Castello G; Esposito G; Stellato G; Dalla Mora L; Abate G; Germano A
    Gynecol Oncol; 1986 Sep; 25(1):61-4. PubMed ID: 3732919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local eosinophilia in stroma of tumors related to prognosis.
    Pastrnák A; Jansa P
    Neoplasma; 1984; 31(3):323-6. PubMed ID: 6738756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated and humoral immune responses to primary oral cancers.
    Cannell H
    J Maxillofac Surg; 1974 Aug; 2(2-3):108-13. PubMed ID: 4533015
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological status of patients in carcinoma head and neck.
    Vasenwala SM; Aziz M; Rattan A; Ahmad KN
    Indian J Cancer; 1989 Sep; 26(3):137-44. PubMed ID: 2630426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of cellular immunity in precancerous conditions and in carcinoma of the portio].
    Bolis PF; Polatti F; Zara C
    Minerva Ginecol; 1979 Jun; 31(6):445-7. PubMed ID: 315039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.